Morgan Stanley
TMO icon

Morgan Stanley’s Thermo Fisher Scientific TMO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.22B Buy
12,877,595
+1,282,165
+11% +$520M 0.34% 43
2025
Q1
$5.77B Buy
11,595,430
+105,141
+0.9% +$52.3M 0.41% 34
2024
Q4
$5.98B Buy
11,490,289
+348,741
+3% +$181M 0.42% 33
2024
Q3
$6.89B Sell
11,141,548
-955,965
-8% -$591M 0.5% 30
2024
Q2
$6.69B Buy
12,097,513
+344,376
+3% +$190M 0.52% 27
2024
Q1
$6.83B Sell
11,753,137
-13,352,351
-53% -$7.76B 0.55% 24
2023
Q4
$13.3B Buy
25,105,488
+12,687,059
+102% +$6.73B 0.59% 23
2023
Q3
$6.29B Buy
12,418,429
+50,736
+0.4% +$25.7M 0.64% 22
2023
Q2
$6.45B Buy
12,367,693
+779,148
+7% +$407M 0.64% 19
2023
Q1
$6.68B Sell
11,588,545
-141,518
-1% -$81.6M 0.72% 13
2022
Q4
$6.46B Buy
11,730,063
+1,764,312
+18% +$972M 0.73% 12
2022
Q3
$5.05B Buy
9,965,751
+21,926
+0.2% +$11.1M 0.69% 13
2022
Q2
$5.4B Buy
9,943,825
+1,627,484
+20% +$884M 0.7% 13
2022
Q1
$4.91B Buy
8,316,341
+33,984
+0.4% +$20.1M 0.66% 14
2021
Q4
$5.53B Buy
8,282,357
+172,299
+2% +$115M 0.68% 16
2021
Q3
$4.63B Sell
8,110,058
-195,995
-2% -$112M 0.62% 20
2021
Q2
$4.19B Buy
8,306,053
+12,811
+0.2% +$6.46M 0.55% 28
2021
Q1
$3.78B Buy
8,293,242
+566,814
+7% +$259M 0.56% 27
2020
Q4
$3.6B Buy
7,726,428
+328,820
+4% +$153M 0.56% 30
2020
Q3
$3.27B Sell
7,397,608
-265,702
-3% -$117M 0.63% 28
2020
Q2
$2.78B Buy
7,663,310
+107,355
+1% +$38.9M 0.61% 28
2020
Q1
$2.14B Sell
7,555,955
-365,463
-5% -$104M 0.58% 27
2019
Q4
$2.57B Buy
7,921,418
+1,294,305
+20% +$420M 0.6% 19
2019
Q3
$1.93B Buy
6,627,113
+2,476,490
+60% +$721M 0.51% 28
2019
Q2
$1.22B Sell
4,150,623
-38,534
-0.9% -$11.3M 0.32% 69
2019
Q1
$1.15B Sell
4,189,157
-325,504
-7% -$89.1M 0.32% 69
2018
Q4
$1.01B Buy
4,514,661
+27,846
+0.6% +$6.23M 0.3% 73
2018
Q3
$1.1B Buy
4,486,815
+104,302
+2% +$25.5M 0.27% 81
2018
Q2
$908M Sell
4,382,513
-65,884
-1% -$13.6M 0.25% 89
2018
Q1
$918M Buy
4,448,397
+4,313
+0.1% +$890K 0.25% 81
2017
Q4
$844M Buy
4,444,084
+188,728
+4% +$35.8M 0.23% 84
2017
Q3
$805M Sell
4,255,356
-280,124
-6% -$53M 0.24% 86
2017
Q2
$791M Sell
4,535,480
-129,402
-3% -$22.6M 0.24% 84
2017
Q1
$717M Buy
4,664,882
+327,826
+8% +$50.4M 0.22% 94
2016
Q4
$612M Sell
4,337,056
-342,938
-7% -$48.4M 0.2% 103
2016
Q3
$744M Sell
4,679,994
-316,323
-6% -$50.3M 0.25% 76
2016
Q2
$738M Sell
4,996,317
-484,082
-9% -$71.5M 0.27% 81
2016
Q1
$776M Sell
5,480,399
-549,781
-9% -$77.8M 0.3% 65
2015
Q4
$855M Buy
6,030,180
+286,391
+5% +$40.6M 0.31% 61
2015
Q3
$702M Buy
5,743,789
+354,876
+7% +$43.4M 0.26% 75
2015
Q2
$699M Buy
5,388,913
+225,392
+4% +$29.2M 0.24% 81
2015
Q1
$694M Sell
5,163,521
-237,372
-4% -$31.9M 0.26% 80
2014
Q4
$677M Buy
5,400,893
+399,760
+8% +$50.1M 0.25% 85
2014
Q3
$609M Buy
5,001,133
+25,162
+0.5% +$3.06M 0.23% 89
2014
Q2
$587M Sell
4,975,971
-105,687
-2% -$12.5M 0.23% 81
2014
Q1
$611M Buy
5,081,658
+73,018
+1% +$8.78M 0.26% 76
2013
Q4
$558M Buy
5,008,640
+601,160
+14% +$66.9M 0.24% 82
2013
Q3
$406M Sell
4,407,480
-162,863
-4% -$15M 0.19% 119
2013
Q2
$387M Buy
+4,570,343
New +$387M 0.2% 119